Wisconsin's biotechnology industry is a thriving sector focused on research and development that impacts health, agriculture, and environmental solutions. Companies here range from those creating innovative therapeutics to those enhancing microbial and agricultural products. Emerging technologies are shaping its future, with significant investments being made in gene therapy and diagnostics. Notably, Wisconsin is home to both well-established players and newer startups, making it a dynamic base for advancements in biotechnology. The state's collaboration with its research institutions further fuels growth, linking scientific exploration with practical applications in everyday life.

The companies featured span various sizes, primarily concentrated in Madison. Established between 1976 and 2021, their specializations include therapeutics, diagnostics, and bio-manufacturing. Promega Corporation and Quincy Bioscience are among the recognized firms leading advancements in life sciences and cognitive health, respectively. Key players harness innovative technologies to address market demands, reflecting an increasing trend toward personalized medicine and health solutions. With an emphasis on quality and regulatory compliance, these organizations contribute significantly to both local economies and the biotechnology sector.

Read on to discover more about Wisconsin's top biotechnology companies.

Top 23 Biotechnology Companies in Wisconsin

1. Promega Corporation

• Website: promega.com
• Ownership type: Venture Capital
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 73%, Germany 5%, France 4%, Other 18%
• Latest funding: December 1984
• Founded year: 1978
• Headcount: 1001-5000
• LinkedIn: promega

Promega Corporation, based in Madison, Wisconsin, is a biotechnology company that specializes in the production of enzymes and other essential products for molecular biology and biotechnology applications. Established in 1978, Promega has built a robust portfolio that includes over 4,000 life science products. The company focuses on key areas such as genomics, protein analysis, and drug discovery, catering to the needs of scientists, researchers, and pharmaceutical companies worldwide. With a workforce of approximately 1,939 employees, Promega operates globally, maintaining branch offices in 16 countries. Their commitment to quality and innovation is evident in their extensive range of products and services, which support various research and clinical applications, including infectious diseases and metabolic disorders. Promega's dedication to advancing scientific research is reflected in their ongoing development of new technologies and solutions for the life sciences community.

2. Invenra

• Website: invenra.com
• Ownership type: Venture Capital
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series B, $7.0M, October 2018
• Founded year: 2011
• Headcount: 51-200
• LinkedIn: invenra

Invenra, founded in 2011 and based in Madison, Wisconsin, is a biotechnology company that specializes in the development of therapeutic bispecific antibodies. The company is dedicated to advancing the discovery and development of novel therapies, particularly targeting oncology and autoimmune diseases. Invenra's proprietary B-Body® platform is central to their operations, enabling high-yield antibody production and addressing complex therapeutic challenges. They actively collaborate with pharmaceutical and biotechnology firms to enhance therapeutic pipelines, showcasing their commitment to innovation in the industry. Invenra has also secured funding, with a Series B round of $7 million in 2018, which underscores their growth potential and the interest of investors in their unique approach to antibody development.

3. Nimble Therapeutics

• Website: nimbletherapeutics.com
• Ownership type: Corporate
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $200.0M, December 2024
• Founded year: 2019
• Headcount: 11-50
• LinkedIn: nimble-therapeutics

Nimble Therapeutics, founded in 2019 and based in Madison, Wisconsin, is a biotechnology company dedicated to developing oral therapies for immune-mediated diseases. The company leverages advanced peptide synthesis technology to create innovative drug candidates that aim to improve patient outcomes. Their focus is on drug discovery, particularly targeting diseases with significant unmet needs. Nimble Therapeutics collaborates with pharmaceutical and biotechnology firms, enhancing their therapeutic offerings through its proprietary discovery engine. The company has recently secured $200 million in funding, which underscores its potential and commitment to advancing its pipeline into clinical trials. Nimble's strategic approach and innovative capabilities position it as a noteworthy entity in the biotechnology industry.

4. Mirus Bio

• Website: mirusbio.com
• Ownership type: Corporate
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 90%, United Kingdom (UK) 7%, China 3%
• Latest funding: $600.0M, May 2024
• Founded year: 1994
• Headcount: 51-200
• LinkedIn: mirus-bio-llc

Mirus Bio, founded in 1994 and based in Madison, Wisconsin, is a biotechnology company that specializes in transfection technologies and protein production solutions. The company is dedicated to providing advanced products that enhance gene therapy and protein expression processes. Their offerings include a range of transfection reagents, expression systems, and tools for viral vector production, which are vital for researchers and companies in the biotechnology and pharmaceutical sectors. Mirus Bio has made significant contributions to the field, particularly in the development of methods that improve the efficiency and safety of gene transfer. They have also received substantial funding, with a reported amount of $600 million in May 2024, underscoring their active engagement and relevance in the biotechnology industry.

5. Cellscript

• Website: cellscript.com
• Ownership type: Private
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 94%, France 6%
• Founded year: 2007
• Headcount: 11-50
• LinkedIn: cellscript

Cellscript, founded in 2007 and based in Madison, Wisconsin, is a private biotechnology company focused on RNA technologies for clinical research and therapeutic applications. The company offers a range of products, including RNA transcription kits and modified nucleotides, designed to improve the efficacy and stability of mRNA. Their flagship products, the INCOGNITO™ RNA Transcription Kits, allow for the synthesis of RNA containing modified nucleosides, which are less likely to trigger immune responses when introduced into mammalian cells. This innovation has significant implications for regenerative medicine, cell therapies, and immunotherapies. Cellscript's commitment to providing high-quality products and technical support makes it a valuable partner for researchers and organizations in the life sciences sector.

6. LifeGen Technologies, LLC

• Website: lifegentech.com
• Ownership type: Corporate
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: Philippines 58%, Romania 21%, United States (USA) 21%
• Latest funding: $11.7M, December 2011
• Founded year: 2000
• Headcount: 1-10
• LinkedIn: lifegen-technologies-llc

LifeGen Technologies, LLC, based in Madison, Wisconsin, is a biotechnology firm that focuses on genomics and aging research. Established in 2000 by Drs. Richard Weindruch and Tomas A. Prolla, the company has pioneered the use of DNA microarrays to analyze gene expression changes associated with aging. LifeGen provides contract research services, gene expression analysis, and consulting aimed at drug and nutraceutical development. The company has developed a proprietary gene expression database that aids in identifying potential health benefits of various products. LifeGen's research has led to several pending patents, and it has received funding from the National Institute on Aging to explore biomarkers related to caloric restriction. This research is crucial as caloric restriction is the only dietary intervention proven to extend lifespan in various species. LifeGen's work positions it as a strategic partner for companies in the pharmaceutical and nutraceutical sectors, seeking to leverage genetic insights to enhance healthspan.

7. BrainXell

• Website: brainxell.com
• Ownership type: Private
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 96%, Singapore 4%
• Latest funding: $13.2M, September 2021
• Founded year: 2015
• Headcount: 11-50
• LinkedIn: brainxell-inc

BrainXell, founded in 2015 and based in Madison, Wisconsin, is a biotechnology company dedicated to advancing research in central nervous system disorders. The company specializes in the development and supply of induced pluripotent stem cell (iPSC)-derived human neurons, astrocytes, microglia, and other cell types. Their offerings include a variety of products tailored for research applications, as well as custom services such as cell differentiation and assay services. BrainXell primarily targets researchers and organizations in the biotechnology and pharmaceutical sectors, providing essential tools for drug discovery and development. The company has received funding amounting to approximately $13.2 million as of September 2021, indicating investor confidence in their mission to enhance research and development in the field of neuroscience.

8. JangoBio

• Website: jango.bio
• Ownership type: Venture Capital
• Headquarters: Fitchburg, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Seed, $112,000, January 2018
• Founded year: 2015
• Headcount: 1-10
• LinkedIn: jangobio

JangoBio, founded in 2015 and based in Fitchburg, Wisconsin, is a biotechnology company that specializes in regenerative therapies aimed at restoring hormone balance to combat aging and age-related diseases. The company is focused on developing innovative stem cell therapies and diagnostic services for both consumers and healthcare providers. JangoBio's research is centered on the science of aging, particularly the role of hormones in health and longevity. They have created hormone-producing organoids designed to replace or regenerate gonadal tissues that decline with age. This approach is intended to address conditions such as hypogonadism, osteoarthritis, and Alzheimer’s disease. JangoBio operates through several subsidiaries, including JangoMed, which targets human health, and JangoPet, which focuses on veterinary applications. The company has received seed funding of $112,500, which supports its ongoing research and development initiatives. JangoBio's commitment to personalized medicine and advanced research positions it as a notable player in the biotechnology sector.

9. Xiogenix

• Website: xiogenix.com
• Ownership type: Family Owned
• Headquarters: Muskego, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2001
• Headcount: 11-50
• LinkedIn: biocut-systems-inc.

Xiogenix, founded in 2001 and based in Muskego, Wisconsin, is a family-owned biotechnology company that specializes in the manufacturing of advanced medical equipment tailored for the bioscience industry. Initially focused on producing steel rule dies for various industries, Xiogenix pivoted to regenerative medicine, developing innovative solutions for cell and gene therapy and tissue banking. Their product line includes state-of-the-art equipment designed to enhance processing efficiency, maintain quality, and ensure safety in medical applications. The company collaborates closely with industry leaders to identify market needs and create solutions that drive progress in regenerative medicine. Xiogenix has also expanded its offerings through strategic partnerships, enhancing its capabilities in the tissue banking sector and entering the cell and gene therapy market. Their commitment to customer service and tailored support further underscores their role in the biotechnology field.

10. Quincy Bioscience

• Website: quincybioscience.com
• Ownership type: Venture Capital
• Headquarters: Middleton, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $239,000, January 2011
• Founded year: 2004
• Headcount: 11-50
• LinkedIn: quincy-bioscience

Quincy Bioscience, based in Middleton, Wisconsin, is a biotechnology company that specializes in cognitive health solutions. Founded in 2004, the company is known for its flagship product, Prevagen, which features the patented ingredient apoaequorin. This ingredient, originally derived from jellyfish, has been the subject of clinical research demonstrating its potential to support memory and cognitive function. Prevagen has gained recognition as a top-selling memory support supplement in chain pharmacies across the United States, including major retailers like Walgreens and CVS. Quincy Bioscience emphasizes quality and compliance with industry standards, ensuring that its products are manufactured in a cGMP compliant facility. The company has also engaged in partnerships with leading researchers and universities to advance its understanding of cognitive health and drive innovation in its product offerings.

11. MicroSynergies

• Website: microsynergies.com
• Ownership type: Private
• Headquarters: Glendale, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 90%, Mexico 10%
• Founded year: 2007
• Headcount: 11-50
• LinkedIn: microsynergies

MicroSynergies is a microbial biotechnology company based in Glendale, Wisconsin, founded in 2007. The company specializes in the production and distribution of microbial cultures and biological products, serving key industries such as agriculture and aquaculture. With a strong emphasis on research and development, MicroSynergies aims to create effective microbial solutions that enhance product performance and sustainability. They operate globally, ensuring a secure supply chain for their customers through a network of manufacturing partners. The company boasts a library of over 40,000 strains of beneficial microorganisms, with more than 4,000 currently in production. Their services include contract manufacturing, blending, and packaging, allowing them to cater to unique customer needs. MicroSynergies has built a reputation for quality and reliability, driven by a management team with extensive experience in the biological products industry.

12. Cedarburg Pharmaceuticals, A Division of AMRI

• Website: cedarburghauser.com
• Ownership type: Corporate
• Headquarters: Grafton, Wisconsin, United States (USA)
• Latest funding: $38.2M, March 2014
• Founded year: 1998
• Headcount: 51-200
• LinkedIn: cedarburg-hauser-pharmaceuticals

Cedarburg Pharmaceuticals, a division of AMRI, operates as a contract development and manufacturing organization (CDMO) based in Grafton, Wisconsin. Founded in 1998, the company has built a reputation for providing comprehensive pharmaceutical and biotechnology services. Their offerings include drug discovery, development, and manufacturing solutions tailored for small molecules and biologics. Cedarburg Pharmaceuticals primarily serves biopharmaceutical companies, helping them streamline their drug development processes. With over 30 years of industry experience, the company emphasizes quality and efficiency in its operations. They have a robust infrastructure that supports a wide range of services, including analytical testing, sterile fill-finish, and process development. Their commitment to innovation and client collaboration further enhances their role in the biotechnology sector.

13. Scientific Protein Laboratories, LLC

• Website: splpharma.com
• Ownership type: Private
• Headquarters: Waunakee, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1976
• Headcount: 201-500
• LinkedIn: spl-pharma.com

Scientific Protein Laboratories, LLC (SPL), founded in 1976 and based in Waunakee, Wisconsin, is a private pharmaceutical manufacturer that specializes in the development and production of active pharmaceutical ingredients (APIs) sourced from biological materials. The company has built a strong portfolio around high-quality heparin products and pancreatic enzymes, serving a wide array of clients in the pharmaceutical, veterinary, and food industries. SPL operates a state-of-the-art manufacturing facility that adheres to strict FDA cGMP standards, ensuring that their products meet rigorous quality and regulatory requirements. With a focus on biopharmaceutical manufacturing services, SPL offers contract process development, analytical testing, and regulatory support, enabling clients to navigate the complexities of bringing new therapeutics to market. Their expertise in fermentation, natural product extraction, and purification processes allows them to cater to both emerging and established biopharmaceutical companies, making them a valuable partner in the industry.

14. Immuto Scientific

• Website: immutoscientific.com
• Ownership type: Venture Capital
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Other (Grant), $100,000, February 2025
• Founded year: 2018
• Headcount: 11-50
• LinkedIn: immuto-scientific

Immuto Scientific, founded in 2018 and based in Madison, Wisconsin, is a biotechnology company focused on advancing drug discovery through innovative protein structural analysis. The company offers specialized services such as epitope mapping and antibody screening, which are crucial for preclinical biotech firms and pharmaceutical companies looking to enhance their drug development processes. Immuto's proprietary technology, including their Plasma Induced Modification of Biomolecules (PLIMB) platform, allows for high-resolution structural insights that improve the efficacy of therapeutic candidates. The company has attracted attention from industry leaders and has received funding, including a grant in February 2025, indicating its active engagement and relevance in the biotechnology sector.

15. Bio-Green Planet

• Website: biogp.com
• Ownership type: Private
• Headquarters: Belgium, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 65%, India 35%
• Founded year: 1988
• Headcount: 11-50
• LinkedIn: bio-green-planet

Bio-Green Planet, based in Belgium, Wisconsin, is a private biotechnology company founded in 1988. The company specializes in the manufacturing of microbial products that enhance agricultural productivity, treat wastewater, and manage livestock waste. With a workforce of 11-50 employees, Bio-Green Planet has established a significant presence in the environmental biotechnology sector. Their products cater to a wide range of applications, including plant health, wastewater treatment, and livestock management. The company serves clients in over 40 countries, showcasing their global reach and impact. Bio-Green Planet operates state-of-the-art laboratories staffed by experienced microbiologists dedicated to developing innovative microbial solutions. Their commitment to research and development allows them to customize products for specific applications, addressing the unique challenges faced by their clients. The company also has several subsidiaries, including Bio-Genesis Technology, Inc. and Applied Biotech Industries, Inc., which further enhance their capabilities in microbial manufacturing and fermentation technologies.

16. Elephas

• Website: elephas.com
• Ownership type: Venture Capital
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series C, $55.0M, January 2024
• Founded year: 2020
• Headcount: 51-200
• LinkedIn: elephasbiosciences

Elephas Biosciences Corporation, founded in 2020 and based in Madison, Wisconsin, is a biopharmaceutical company dedicated to enhancing cancer treatment through advanced imaging and diagnostics. The company specializes in providing biopharma services and clinical diagnostics that aim to predict patient responses to immunotherapy. Elephas operates primarily in the United States and Canada, serving a clientele that includes biopharmaceutical companies and academic institutions. Their unique ex vivo platform utilizes live tumor fragments to maintain the integrity of the tumor microenvironment, allowing for more accurate assessments of drug candidates. Recently, Elephas secured $55 million in Series C funding, which underscores the growing interest and investment in their innovative approach to cancer diagnostics and treatment. They are also involved in multiple clinical trials to validate their platform, further solidifying their role in the biotechnology industry.

17. Genus IntelliGen Technologies

• Website: genusintelligen.com
• Ownership type: Private
• Headquarters: Windsor, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 77%, India 6%, New Zealand 6%, Other 10%
• Founded year: 2017
• Headcount: 51-200
• LinkedIn: genus-intelligen-technologies

Genus IntelliGen Technologies, founded in 2017 and based in Windsor, Wisconsin, is a biotechnology firm dedicated to advancing animal genetics. The company specializes in innovative solutions such as laser-ablation semen sexing technology and sexed bovine genetics, aimed at improving breeding practices for dairy and beef farmers. Their mission is to help producers achieve their genetic objectives efficiently, thereby enhancing productivity and sustainability in animal agriculture. With a team that combines expertise in biology, engineering, and bio-manufacturing, Genus IntelliGen Technologies is committed to delivering high-quality genetic products and services. They operate under the umbrella of Genus plc, which emphasizes a vision of pioneering animal genetic improvement to support global food needs. Their technology not only aids in producing more female calves, which are essential for milk production, but also reduces risks associated with external sourcing of livestock. This positions them as a significant player in the biotechnology sector focused on agricultural applications.

18. NorthStar Medical Radioisotopes, LLC

• Website: northstarnm.com
• Ownership type: Venture Capital
• Headquarters: Beloit, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Other (Grant), $37.0M, August 2021
• Founded year: 2006
• Headcount: 201-500
• LinkedIn: northstar-medical-radioisotopes-llc

NorthStar Medical Radioisotopes, LLC, based in Beloit, Wisconsin, is a pharmaceutical company that specializes in the development and manufacturing of radiopharmaceuticals, particularly aimed at cancer treatment. Founded in 2006, the company has carved out a niche in the biotechnology sector by focusing on innovative production methods for critical isotopes like Actinium-225 and Copper-67. These isotopes are essential for advanced cancer therapies, and NorthStar is pioneering non-reactor-based production processes that are environmentally friendly and scalable. Their operations also include contract development and manufacturing services, catering to healthcare providers and institutions that require these specialized therapies. With a workforce of approximately 295 employees, NorthStar is actively engaged in enhancing the availability of radiopharmaceuticals, which are increasingly vital for treating serious diseases. The company has secured substantial funding, including a notable grant of $37 million in 2021, underscoring its ongoing relevance and potential for growth in the biotechnology industry.

19. BellBrook Labs

• Website: bellbrooklabs.com
• Ownership type: Venture Capital
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Seed, $187,000, June 2012
• Founded year: 2002
• Headcount: 11-50
• LinkedIn: bellbrook-labs

BellBrook Labs, founded in 2002 and based in Madison, Wisconsin, is a biotechnology company that specializes in high-throughput screening (HTS) assay kits and enzyme assay solutions tailored for drug discovery. The company serves pharmaceutical and biotechnology firms, providing essential tools and services that enhance research and development efficiency. With a dedicated team of approximately 19 employees, BellBrook Labs emphasizes delivering high-quality data and expert support to facilitate the drug discovery process. Their product range includes various assay kits, recombinant enzymes, and assay development services, showcasing their commitment to advancing biochemical research. Although the company has not reported recent funding, its established presence and ongoing contributions to the industry highlight its significance in the biotechnology sector.

20. Novir

• Website: novir-usa.com
• Ownership type: Private
• Headquarters: Milwaukee, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Other (Debt), $2.3M, September 2024
• Founded year: 2020
• Headcount: 51-200
• LinkedIn: novir

Novir is a healthcare service provider based in Milwaukee, Wisconsin, specializing in preventive health solutions. Founded in 2020, the company emerged in response to the urgent need for reliable testing during the COVID-19 pandemic. Novir offers a range of services, including lead testing, vaccinations, and drug screening, aimed at empowering individuals and organizations to take charge of their health. The company serves a variety of clients, including public health entities, educational institutions, and employers, providing accessible health services and innovative testing solutions. Novir has received funding amounting to approximately $2.27 million, reflecting its growth and the confidence investors have in its mission to enhance public health through proactive measures. With a focus on technology integration and a commitment to improving health outcomes, Novir is positioned as a significant player in the biotechnology sector.

21. Wisconsin BioProducts

• Website: wisbio.com
• Ownership type: Private
• Headquarters: Milwaukee, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2000
• Headcount: 11-50
• LinkedIn: wisconsinbioproducts

Wisconsin BioProducts, established in 2000 and based in Milwaukee, Wisconsin, operates as a contract manufacturing organization (CMO) specializing in custom fermentation and product recovery services. The company serves a variety of industries, including pharmaceuticals, agriculture, and nutraceuticals, by providing tailored solutions for fermentation processes. With over 40 years of combined experience in life sciences and bioprocess engineering, Wisconsin BioProducts focuses on producing a wide range of bio-materials used in everyday consumer and industrial products. Their facilities boast a fermentation vessel capacity of approximately 165,000 liters, allowing them to handle projects from proof-of-concept to full-scale production. The company emphasizes quality and compliance in its manufacturing processes, ensuring that all products meet or exceed industry standards. Their commitment to customer satisfaction and innovative production strategies positions them as a valuable partner in the biotechnology field.

22. Venture Investors Health Fund

• Website: ventureinvestors.com
• Ownership type: Private
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1984
• Headcount: 1-10
• LinkedIn: venture-investors

Venture Investors Health Fund, based in Madison, Wisconsin, is a private venture capital firm founded in 1984. The firm specializes in healthcare innovations, focusing on early-stage startups in the medical devices, biopharma, and digital health sectors. With a team that combines venture capital expertise and operational experience, they provide not only capital but also strategic support to help these startups develop and commercialize their technologies. Their portfolio includes notable companies like TomoTherapy, NeuWave Medical, and LenSx, which have made significant contributions to healthcare technology. Venture Investors manages approximately $275 million in assets, reflecting their active engagement in the healthcare investment space. They leverage their connections with research universities and vibrant communities to identify and nurture promising healthcare ideas, aiming to shape the future of health and wellness.

23. Flownamics, Inc.

• Website: flownamics.com
• Ownership type: Private
• Headquarters: Madison, Wisconsin, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1995
• Headcount: 11-50
• LinkedIn: flownamics-inc-

Flownamics, Inc., founded in 1995 and based in Madison, Wisconsin, is a biotechnology company that specializes in bioprocess development and automation. The company designs and manufactures automated sampling systems and analytical integrations that are essential for monitoring bioprocess cultures in the biotechnology and pharmaceutical industries. Their products, such as the Seg-Flow sampling systems, are engineered to optimize fermentation and bioreactor processes, ensuring operational efficiency and consistency. Flownamics has been at the forefront of innovation in this field, continuously developing new technologies to meet the evolving needs of their clients. Their commitment to quality and customer support has established them as a trusted partner in bioprocess automation.

Biotechnology Insights: Key Companies in Wisconsin

Want to Find More Biotechnology Companies?

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!